Consensus Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2024 BST			5-day change	1st Jan Change
50.43 ^USD	-0.41%		-3.21%	+170.98%

06-04	Health Care Climbs on Defensive Bias - Health Care Roundup	DJ
06-04	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

Evolution of the average Target Price on Viking Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d37e48f88beb7829142e152b1e.WSoyHdBNxcpWlJozrSIWfF-sQxHu9pH2x6ei3Uh5BD8.HHNDW4YGq6Ez5OJJ4WFGHhr-DXSkptq7tfbLiCcjQE9pHUpEvhn8nTL7yw~d97e10625257d7fce36421d626f3ee0a

Analyst Recommendations on Viking Therapeutics, Inc.

Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform	05-17	MT
Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing	05-06	MT
Viking Therapeutics Insider Sold Shares Worth $22,136,474, According to a Recent SEC Filing	05-03	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $138 From $116, Maintains Outperform Rating	03-27	MT
Stifel Adjusts Viking Therapeutics Price Target to $95 From $80, Maintains Buy Rating	03-26	MT
BTIG Raises Price Target on Viking Therapeutics to $100 From $86, Keeps Buy Rating	03-15	MT
Jefferies Starts Viking Therapeutics With Buy Rating, $110 Price Target	03-07	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $116 From $46, Maintains Outperform Rating	02-28	MT
HC Wainwright Raises Price Target on Viking Therapeutics to $90 From $33, Keeps Buy Rating	02-27	MT
Stifel Adjusts Price Target on Viking Therapeutics to $35 From $30, Maintains Buy Rating	02-14	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $46 From $40, Maintains Outperform Rating	02-08	MT
Raymond James Adjusts Viking Therapeutics Price Target to $37 From $35, Maintains Outperform Rating	17/05/23	MT
Stifel Adjusts Viking Therapeutics' Price Target to $30 From $25, Keeps Buy Rating	16/05/23	MT
BTIG Adjusts Viking Therapeutics' Price Target to $36 From $31, Keeps Buy Rating	16/05/23	MT
Roth MKM Adjusts Price Target on Viking Therapeutics to $24 From $19, Maintains Buy Rating	03/05/23	MT
HC Wainwright Adjusts Price Target on Viking Therapeutics to $33 From $21, Maintains Buy Rating	27/04/23	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $35 From $30, Maintains Outperform Rating	25/04/23	MT
BTIG Research Adjusts Viking Therapeutics Price Target to $31 From $20, Maintains Buy Rating	29/03/23	MT
Raymond James Adjusts Viking Therapeutics Price Target to $35 From $12, Maintains Outperform Rating	29/03/23	MT
Stifel Nicolaus Adjusts Viking Therapeutics Price Target to $25 From $22, Maintains Buy Rating	28/03/23	MT
Stifel Initiates Viking Therapeutics at Buy With $22 Price Target	17/03/23	MT
Raymond James Adjusts Price Target on Viking Therapeutics to $12 From $11, Maintains Outperform Rating	09/02/23	MT
Oppenheimer Adjusts Viking Therapeutics' Price Target to $17 From $15, Maintains Outperform Rating	09/02/23	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $15 From $13, Maintains Outperform Rating	30/01/23	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $13 From $10, Maintains Outperform Rating	20/12/22	MT